Tokyo, Japan

Mine Higuchi

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 1.1

ph-index = 1

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 1999-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Mine Higuchi

Introduction

Mine Higuchi is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance the efficacy of saccharide-degrading enzymes. With a total of 4 patents to her name, Higuchi continues to push the boundaries of innovation in her field.

Latest Patents

Higuchi's latest patents include a pharmaceutical composition that features a lyophilized saccharide-degrading enzyme with an excellent titer. This composition is designed as a unit dose formulation, containing a titer of not less than 0.3 unit/μg as an active ingredient. The formulation includes the enzyme in an amount ranging from 2 μg to 6 μg. Additionally, she has developed a package and method for producing the same, which ensures that the reduction in titer caused by a low amount of enzyme is suppressed. The package comprises a pharmaceutical composition and a container, with the inner surface of the container made from materials such as fine ceramics, silicone resins, and fluorine resins.

Career Highlights

Mine Higuchi is currently associated with Seikagaku Corporation, where she applies her expertise in pharmaceutical innovations. Her work has been instrumental in advancing the understanding and application of saccharide-degrading enzymes in medical formulations.

Collaborations

Higuchi collaborates with various professionals in her field, including her coworker Shin-ichi Ishikawa. Their combined efforts contribute to the ongoing research and development of innovative pharmaceutical solutions.

Conclusion

Mine Higuchi's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking in science. Her patents reflect a commitment to improving medical formulations and enhancing therapeutic efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…